Your browser doesn't support javascript.
loading
The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial
Holgersson, Georg; Bergqvist, Michael; Nilsson, Jonas; Thureson, Marcus; Harmenberg, Johan; Bergstrom, Stefan.
Afiliação
  • Holgersson G; Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden.
  • Bergqvist M; Center for Research and Development, Uppsala University/ County Council of Gävleborg, Gävle Hospital, Gävle, Sweden. Email: georg.holgersson@regiongavleborg.se
Asian Pac J Cancer Prev ; 18(6): 1555-1560, 2017 06 25.
Article em En | MEDLINE | ID: mdl-28669167
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article